ArticleClinical and translational medicine2024
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.
Abstract readLetterCase Reports
In one paragraph
Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies.Cancer · 2025Article
- Nutrition and Diet Patterns as Key Modulators of Metabolic Reprogramming in Melanoma Immunotherapy.Journal of clinical medicine · 2025Review
- Targeting the epigenome and tumor heterogeneity: advances in immunotherapy for chemoresistant metastatic colorectal cancer.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors.
Natália Pinto de AlmeidaLaboratory of Proteomics/LADETEC, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Ágnes Judit JánosiDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Runyu HongInstitute for Systems Genetics, NYU Grossman School of Medicine, New York City, New York, USA.ORCID 0000-0002-0941-351X
Ahmad RajehDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Fábio NogueiraLaboratory of Proteomics/LADETEC, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Leticia SzadaiDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Beata SzeitzDepartment of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.ORCID 0000-0001-6414-0537
Indira Pla ParadaSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.ORCID 0000-0002-0839-7829
Viktória Doma2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
Nicole WoldmarClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Jéssica GuedesLaboratory of Proteomics/LADETEC, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Zsuzsanna ÚjfaludiDepartment of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Aron BarthaDepartment of Bioinformatics, Semmelweis University, Budapest, Hungary.
Yonghyo KimData Convergence Drug Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon, South Korea.
Charlotte WelinderDivision of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Bo BaldetorpDivision of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Lajos Vince KeményDepartment of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Zoltan PahiDepartment of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Guihong WanDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Nga NguyenDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Tibor PankotaiDepartment of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Balázs GyőrffyDepartment of Bioinformatics, Semmelweis University, Budapest, Hungary.
Krzysztof PawłowskiSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
Peter HorvatovichClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Attila Marcell SzaszDepartment of Bioinformatics, Semmelweis University, Budapest, Hungary.
Aniel SanchezSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
Magdalena KurasClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.ORCID 0000-0002-9479-423X
Jimmy Rodriguez MurilloClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Lazaro BetancourtSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.ORCID 0000-0001-8207-7041
Gilberto B DomontProteomics Unit, Institute of Chemistry, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.
Yevgeniy R SemenovDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kun-Hsing YuDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Ho Jeong KwonChemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.ORCID 0000-0002-6919-833X
István Balázs NémethDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
David FenyőInstitute for Systems Genetics, NYU Grossman School of Medicine, New York City, New York, USA.
Elisabet WieslanderSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
György Marko-VargaClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Jeovanis GilSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.ORCID 0000-0003-3601-3893
Funding
Robust, Generalizable, and Fair Machine Learning Models for BiomedicineR35GM142879 · NIGMS · HARVARD MEDICAL SCHOOL · PI YU, KUN-HSING · 2021 to 2025
$2.4MMitigating Hematologic Adverse Events in Patients with Myeloid Malignancies: A Novel Causal Artificial Intelligence ApproachR01HL174679 · NHLBI · HARVARD MEDICAL SCHOOL · PI Kun-Hsing Yu · 2024 to 2026
$2.3MExplainable Artificial Intelligence for Melanoma Recurrence Prediction via Integrative Modeling of Multiplexed Imaging with Transcriptomics and HistopathologyK99CA286966 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WAN, GUIHONG · 2024 to 2025
$352kApotekarsocieteten 2023-0324-HT-PDCAPES 88887.130697CNPq 308341-2019-8CNPq 440613/2016-7DOD Peer Reviewed Cancer Research Program HT9425-23-1-0523FAPERJ E-26/210.173/2018Fru Berta Kamprads StiftelseIngaBritt och Arne Lundbergs ForskningsstiftelseNCI NIH HHS K99 CA286966NCI NIH HHS L30 CA264747NHLBI NIH HHS R01 HL174679NIGMS NIH HHS R35 GM142879NIGMS NIH HHS R35GM142879
Abstract
PubMed holds no abstract for this paper.
Indexed as
MelanomaProto-Oncogene Proteins B-rafFemaleHumansMaleMiddle AgedMitochondriaMutationNeoplasm MetastasisBRAF protein, humanProto-Oncogene Proteins B-raf
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.